company background image
ONTX

Onconova Therapeutics NasdaqCM:ONTX Stock Report

Last Price

US$0.87

Market Cap

US$18.1m

7D

4.3%

1Y

-50.3%

Updated

27 Jan, 2023

Data

Company Financials +

Onconova Therapeutics, Inc.

NasdaqCM:ONTX Stock Report

Mkt Cap: US$18.1m

ONTX Stock Overview

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer.

ONTX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Onconova Therapeutics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Onconova Therapeutics
Historical stock prices
Current Share PriceUS$0.87
52 Week HighUS$2.06
52 Week LowUS$0.62
Beta1.53
1 Month Change36.69%
3 Month Change20.43%
1 Year Change-50.27%
3 Year Change-83.08%
5 Year Change-99.72%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Onconova Therapeutics (NASDAQ:ONTX) Is In A Good Position To Deliver On Growth Plans

Jul 27
Onconova Therapeutics (NASDAQ:ONTX) Is In A Good Position To Deliver On Growth Plans

Will Onconova Therapeutics (NASDAQ:ONTX) Spend Its Cash Wisely?

Mar 21
Will Onconova Therapeutics (NASDAQ:ONTX) Spend Its Cash Wisely?

Companies Like Onconova Therapeutics (NASDAQ:ONTX) Are In A Position To Invest In Growth

Dec 06
Companies Like Onconova Therapeutics (NASDAQ:ONTX) Are In A Position To Invest In Growth

Shareholder Returns

ONTXUS PharmaceuticalsUS Market
7D4.3%-0.5%2.3%
1Y-50.3%5.4%-9.7%

Return vs Industry: ONTX underperformed the US Pharmaceuticals industry which returned 7.9% over the past year.

Return vs Market: ONTX underperformed the US Market which returned -8.5% over the past year.

Price Volatility

Is ONTX's price volatile compared to industry and market?
ONTX volatility
ONTX Average Weekly Movement11.3%
Pharmaceuticals Industry Average Movement11.1%
Market Average Movement6.9%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.9%

Stable Share Price: ONTX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: ONTX's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199815Steve Fruchtmanhttps://www.onconova.com

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company develops a Phase Ib/II ISS with rigosertib monotherapy in patients with advanced squamous cell carcinoma associated with recessive dystrophic epidermolysis bullosa; and has a preclinical program comprising IV/oral rigosertib for COVID-19.

Onconova Therapeutics, Inc. Fundamentals Summary

How do Onconova Therapeutics's earnings and revenue compare to its market cap?
ONTX fundamental statistics
Market CapUS$18.11m
Earnings (TTM)-US$17.31m
Revenue (TTM)US$226.00k

80.1x

P/S Ratio

-1.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ONTX income statement (TTM)
RevenueUS$226.00k
Cost of RevenueUS$0
Gross ProfitUS$226.00k
Other ExpensesUS$17.53m
Earnings-US$17.31m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.83
Gross Margin100.00%
Net Profit Margin-7,658.41%
Debt/Equity Ratio0%

How did ONTX perform over the long term?

See historical performance and comparison